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ABSTRACT: Five new aristolactam alkaloids (1-5), dasymaschalolactams A-E, and the first 
isolation of dasymaschalolactone (17) as a natural product, together with 19 known compounds 
(6-16, and 18-25) were isolated from the twig extract of Dasymaschalon dasymaschalum. Their 
structures were elucidated by spectroscopic methods as well as comparisons made from the 
literature. Compounds 20 and 21 showed α-glucosidase inhibitory activities with IC50 values of 
4.5 and 24.7 µM, respectively.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
3 
 
            Diabetes mellitus (DM) is a non-communicable disease that has become a major public 
health problem, affecting 1.6 million people worldwide in 2016.1,2 This disease is characterized 
by hyperglycemia resulting from the inability to produce (type 1) or use insulin (type 2).3 The 
main risk factor leading to DM, especially type 2, is food consumption4 leading to high glucose 
levels in the blood. α-Glucosidases carry out the digestive breakdown of dietary polysaccharides, 
oligosaccharides, and disaccharides to glucose,5 a key step in the control of the amount of 
glucose in the blood.  Drugs such as acarbose and miglitol used to decrease and control blood 
glucose levels are available on the market, but these can have undesired side effects and hence 
lead to poor compliance.6 Hence, the discovery of α-glucosidase inhibitors from natural sources 
that can postpone the release of glucose from dietary carbohydrates and delay glucose absorption 
without or with less side effects is desirable.  
Plants of the genus Dasymaschalon are small- to medium sized-trees belonging to the 
family Annonaceae. This genus consists of about 40 species worldwide that are distributed 
throughout tropical countries in Asia (particularly in Thailand and the Malaysian peninsular) and 
Africa. In Thailand, only 12 species are recognized.7  Previous phytochemical investigations on 
this genus have resulted in the isolation of various classes of compounds including flavonoids,8 
triterpenoids,8 alkaloids,9,10 neolignans,11 benzyl benzoate derivatives,8,11 phenylpropanoids,12 
acetogenins,13 and oxygenated cyclohexene derivatives.10,14 Some of these compounds have 
shown interesting biological properties including cytotoxicity,8-11,14 antimalarial,10 anti-
inflammatory14 and anti-HIV effects.12,14 Dasymaschalon dasymaschalum (Blume) I.M. Turner 
has many synonym names, including D. blumei Finet & Gagnep., D. coelophloeum (Scheff.) 
Merr., and Desmos dasymaschalus (Blume) Saff.15 The powdered stems of this plant have been 
used as an antipyretic drug.9 The isolation of aristolactams, aporphine alkaloids, flavonoids, 
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benzyl benzoate derivatives, and terpenoids have been reported from this plant.8,9 In a 
preliminary screening of the biological activities of Annonaceae plants, we found that the EtOAc 
extract of the twigs of D. dasymaschalum exhibited good α-glucosidase inhibitory activity with 
89% inhibition at 200 g/mL, which prompted an investigation of the chemical constituents from 
this extract. Herein, the isolation, structural elucidation, and α-glucosidase inhibitory activities of 
the phytochemicals from this plant are described.  
Twenty-five compounds, including 11 aristolactam alkaloids (1-11), one isoquinoline 
alkaloid (12), four flavonoids (13-16), a lactone (17), three benzyl benzoate derivatives (18, 19 
and 25), two amides (20 and 21), two polyoxygenated cyclohexenes (22 and 23), and one 
benzene derivative (24) were isolated and characterized from the EtOAc extract of the twigs of 
D. dasymaschalum. All of the new compounds (1-5) were found to be aristolactam derivatives. 
Compound 17, an isobenzofuran-1(3H)-one derivative, was isolated for the first time from 
Nature. The known compounds were characterized as oldhamactam (6),16,17 velutinam (7),18 
enterocarpam-III (8),19 griffithinam (9),20 goniopedalin (10),21 taliscanine (11),21 duguevalline 
(12),22 desmethoxykanugin (13),23 7,8-dimethoxy-5-hydroxyflavone (14),24 alpinetin (15),25 8-
hydroxynaringenin-4'-methyl ether (16),26 7-methoxyisobenzofuran-1(3H)-one (17),27 benzyl 
benzoate (18),28 2-methoxybenzyl benzoate (19),28 paprazine (20),29 N-trans-feruloyltyramine 
(21),30 (–)-zeylenol (22),31 (+)-crotepoxide (23),32 4-hydroxybenzaldehyde (24),33 and 2-
phenylethyl benzoate (25),34 by comparison of their spectroscopic and physical data with 
published values.  
Dasymaschalolactam A (1) was isolated as a yellow viscous oil, and its molecular 
formula, C19H17NO5, was deduced from the NMR and the HRESITOFMS data, which displayed 
an ion at m/z [M + Na]+ 362.1001 (calcd for C19H17NO5Na, 362.1004). The 
1H and 13C NMR 
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data of 1 (Tables 1 and 2) showed resonances for an ABC pattern of aromatic protons [δH 8.86 
(d, J = 8.5 Hz, H-5), 7.51 (t, J =8.5 Hz, H-6), and 7.17 (d, J = 8.5 Hz, H-7)], one aromatic proton 
[δH 7.73 (s, H-9)], four methoxy groups [δH 4.51 (s, CH3O-2), 4.19 (s, CH3O-3), 4.00 (s, CH3O-
4), and 4.07 (s, CH3O-8)], and one NH proton [δH 9.86 (brs, NH)]. The latter assignment was 
consistent with the IR spectrum, which displayed an absorption band at 3224 cm-1.35 The 13C 
NMR spectrum of 1 displayed 19 resonances including those for 14 sp2 carbons, one lactam 
carbonyl carbon, and four methoxy carbons. These NMR spectroscopic data were closely related 
to that of stigmalactam isolated from Fissistigma oldhamii.35 The major difference was the 
splitting pattern of the aromatic protons on the D ring. Stigmalactam showed an ABX pattern35 
for H-5, H-7, and H-8 while compound 1 showed resonances for an ABC pattern for H-5, H-6, 
and H-7. In addition, an additional methoxy proton resonance was also observed at δH 4.07 
which was assigned to OMe-8 on the basis of the HMBC correlations shown in Figure 1. The 
structure of compound 1 was determined as shown. 
Dasymaschalolactam B (2) gave the same molecular formula, C19H17NO5 
[HRESITOFMS m/z 340.1186 (calcd for C19H18NO5, 340.1185)] as dasymaschalolactam A (1). 
The NMR data (Tables 1 and 2) as well as the HMBC correlations  (Figure 1) were almost 
identical to those of 1, except that the 1H NMR spectrum of 2 displayed an ABC pattern for H-6 
(δH 7.16, dd, J = 7.7, 1.1 Hz), H-7 (δH 7.52, t, J = 7.7 Hz), and H-8 (δH 7.49, dd, J = 7.7, 1.1 Hz). 
The HMBC correlations shown in Figure 1 confirmed the structure of dasymaschalolactam B as 
shown. 
The molecular formula of dasymaschalolactam C (3) [C18H15NO5, HRESITOFMS m/z 
348.0849 [M + Na]+ (calcd for C18H15NO5Na, 348.0848)] indicated 3 to have one CH3 group less 
than 2. The NMR spectroscopic data of 3 (Tables 1 and 2) were almost identical to those of 2 
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except the methoxy group resonance (δH 4.09) at C-5 of 2 was replaced by that for a hydroxy 
group (δH 10.88) in 3. This was further confirmed by the HMBC correlations between the OH-5 
(δH 10.88) with C-4b (δC 113.6), C-5 (δC 154.7), and C-6 (δC 113.8). The structure of 3 was 
established as depicted.  
Dasymaschalolactam D (4) gave a molecular formula of C18H16NO5, as indicated from its 
NMR and HRESITOFMS data ([M + H]+ m/z 326.1031, calcd 326.1028). Analysis of the NMR 
spectroscopic data of 4 (Tables 1 and 2) showed that its structure is closely related to that of 3. 
The main difference found was that the methoxy group at C-4 of 3 was replaced by a hydroxy 
group in 4. This was further supported by the HMBC correlations shown in Figure 1. Hence, the 
structure of 4 was proposed as shown. 
Dasymaschalolactam E (5) showed a molecular formula of C17H14NO4, which was 
deduced from its NMR and HRESITOFMS data ([M + H]+ m/z 296.0927, calcd 296.0923). 
Compound 5 was also demonstrated to be an aristolactam derivative, from its 1H NMR 
spectroscopic data (Tables 1 and 2), which showed two singlet aromatic proton resonances at δH 
7.71 (s, H-2) and 7.14 (s, H-9), a set of ABX aromatic proton resonances at δH 9.24 (d, J = 9.0 
Hz, H-5), 7.19 (dd, J = 9.0, 2.8 Hz, H-6), and 7.44 (d, J = 2.8 Hz, H-8), and two methoxy group 
resonances at δH 3.96 (s, CH3O-7), 4.13 (s, CH3O-3). The observed HMBC correlations (Figure 
1) confirmed the structure of 5 as shown. 
Dasymaschalolactone, [7-methoxyisobenzofuran-1(3H)-one] (17), showed a protonated 
molecular ion at m/z 165.0553 [M + H]+ (calcd for 165.0552) in the HRESITOFMS, 
corresponding to the molecular formula C9H9O3. Compound 17 was a simple isobenzofuran-
1(3H)-one derivative that displayed 1H NMR resonances for an ABC pattern of aromatic protons 
[δH 7.16 (dd, J = 7.5, 0.8 Hz, H-4), 7.72 (dd, J = 8.2, 7.5 Hz, H-5), and 7.11 (d, J = 8.2 Hz, H-6)], 
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one oxymethylene group of a lactone ring [δH 5.28 (s, H-3)], and one methoxy group [3.96 (s, 
CH3O-5)]. Compound 17 was one of the key products from the regiocontrolled rearrangement of 
isobenzofuran.27 This is the first report of the isolation of 17 from Nature. 
 Most of the isolated compounds (1-4, 7-8, 10-11, 13, 15-16, 18-21, and 24) were 
evaluated for their α-glucosidase activity. Of the compounds listed, amides 20 and 21 exhibited 
good α-glucosidase inhibitory activities with IC50 values at 4.5 and 24.7 µM, which were more 
active than the positive control, acarbose, (IC50 value = 73.7 µM) while flavanone 16 showed a 
weaker α-glucosidase inhibitory activity (IC50 value = 256.5 µM) than that of acarbose.  
EXPERIMENTAL SECTION 
 General Experimental Procedures. The general information on instruments and 
chromatographic materials was the same as in previous reports.36-40 
 Plant Material. The twigs of D. dasymaschalum were collected in May 2018 from Kuan 
Khao Wang Literary Botanic Garden, Chalung, Hat Yai District, Songkhla Province, Thailand. 
The plant was identified by one of the authors (S.L.) from a comparison with the authentic plant 
growing in Mae Fah Luang University. A voucher specimen (MFU-NPR0191) was deposited at 
the Natural Products Research Laboratory of Mae Fah Luang University. 
 Extraction and Isolation. The chopped and air-dried twigs of D. dasymaschalum (5.6 
kg) were extracted with EtOAc (10 L) at room temperature and concentrated under reduced 
pressure to provide an EtOAc extract (120.7 g). This crude extract was subjected to quick 
column chromatography (QCC) over silica gel (100% hexanes to 100% EtOAc) to give eight 
fractions (Fr.D1Fr.D8). Fr.D2 and Fr.D3 were combined (8.5 g) and fractionated over Sephadex 
LH-20 (100% MeOH) to give seven further fractions (Fr.D2.3AFr.D2.3G). Compounds 22 (3.2 
mg) and 23 (6.7 mg) were obtained from Fr.D2.3D (497.5 mg) by CC (3:2 acetone in hexanes). 
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Purification of Fr.D2.3E (389 mg) by CC (1:3 EtOAc in hexanes) gave 11 (2.6 mg), together with 
11 fractions (Fr.D2.3EA Fr.D2.3EU). Compound 2 (7.2 mg) was obtained from Fr.D2.3EH (10.5 
mg) by CC (1:3 EtOAc in hexanes), whereas 1 (3.1 mg, tR 15.4 min), 3 (2.5 mg, tR 17.5 min), 
and 6 (0.7 mg, tR 20.1 min) were obtained from Fr.D2.3D (120 mg) by RP C18 HPLC (1.2:0.8 
CH3CN in H2O, 2.0 mL/min). Fr.D4 and Fr.D5 were combined (3.3 g) and further separated by 
CC (1:4 MeOH in CH2Cl2) to give six fractions (Fr.D4.5AFr.D4.5F). Fr.D4.5B (2.4 g) was 
subjected to CC (1:4 EtOAc in CH2Cl2) to yield six fractions (Fr.D4.5BAFr.D4.5BF). Compound 
19 (3.7 mg) was isolated from Fr.D4.5BB (35.7 mg) by CC (2:4 EtOAc in hexanes). Purification 
of Fr.D4.5BD (98.7 mg) by CC (2:4 EtOAc in hexanes) yielded 18 (5.7 mg). Purification of 
Fr.D4.5C (40.2 mg) over Sephadex LH-20 (100% MeOH) gave 14 (4.2 mg) and 15 (5.1 mg). 
Fractionation of Fr. D6 (2.34 g) by Sephadex LH-20 (100% MeOH) gave five fractions 
(Fr.D6AFr.D6E). Compound 4 (2.4 mg) was obtained from Fr.D6C (70.3 mg) by CC (1:4 
MeOH in CH2Cl2). Fr.D6E (257.4 mg) was subjected to RP C18 HPLC (1.2:0.8 CH3CN in H2O, 
2.0 mL/min) to give compound 7 (1.3 mg, tR 20.5 min). Separation of Fr.D6D (102.7 mg) over 
Sephadex LH-20 (100% MeOH) yielded six subfractions (Fr.D6DAFr.D6DF). Compounds 20 
(10.5 mg) and 21 (13.5 mg) were isolated from Fr.D6DD (51.6 mg) by CC (1:4 MeOH in 
CH2Cl2). Fr.D6DE (30.5 mg) was subjected to Sephadex LH-20 CC (100% MeOH) to yield 
compounds 12 (0.5 mg) and 16 (3.5 mg). Compounds 5 (3.0 mg), 8 (2.5 mg), 9 (2.0 mg), and 10 
(2.1 mg) were obtained from Fr. D6DF (58.6 mg) by CC (1:3 EtOAc in CH2Cl2) while 17 (1.5 
mg), 24 (2.5 mg), and 25 (2.1 mg) were obtained from Fr. D6DB (24.5 mg) by CC (1:4 MeOH in 
CH2Cl2). 
 Dasymaschalolactam A (1): yellow viscous oil; UV (MeOH) λmax (log ε) 358 (2.76), 279 
(3.58), 235 (3.52), 214 (3.55) nm; IR (neat) νmax 3224, 2998, 1670, 1448, 1350, 1287 cm
-1; 1H 
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and 13C NMR, see Tables 1 and 2; HRESITOFMS m/z 362.1001 [M + Na]+ (calcd for 
C19H17NO5Na, 362.1004). 
Dasymaschalolactam B (2): light yellow viscous oil; UV (MeOH) λmax (log ε) 399 (2.66), 
276 (3.39), 258 (3.44), 229 (3.29), 204 (3.38) nm; IR (neat) νmax 3241, 2939, 1688, 1378, 1083 
cm-1; 1H and 13C NMR, see Tables 1 and 2; HRESITOFMS m/z 340.1186 [M + H]+ (calcd for 
C19H18NO5, 340.1185). 
Dasymaschalolactam C (3): yellow viscous oil; UV (MeOH) λmax (log ε) 400 (2.69), 257 
(3.52), 233 (3.37) nm; IR (neat) νmax 3203, 2925, 2858, 1694, 1468, 1382 cm
-1; 1H and 13C NMR, 
see Tables 1 and 2; HRESITOFMS m/z 348.0849 [M + Na]+ (calcd for C18H15NO5Na, 
348.0848). 
Dasymaschalolactam D (4): brown viscous oil; UV (MeOH) λmax (log ε) 396 (2.64), 276 
(3.41), 258 (3.47), 233 (3.42), 204 (3.32) nm; IR (neat) νmax 3241, 2935, 1682, 1383, 1260, 1076 
cm-1; 1H and 13C NMR, see Tables 1 and 2; HRESITOFMS m/z 326.1031 [M + H]+ (calcd for 
C18H16NO5, 326.1028). 
Dasymaschalolactam E (5): yellow viscous oil; UV (MeOH) λmax (log ε) 335 (3.18), 284 
(3.87), 234 (3.72), 215 (3.75) nm; IR (neat) νmax 3224, 2942, 1678, 1605, 1376, 1109, 1035 cm
-1; 
1H and 13C NMR, see Tables 1 and 2; HRESITOFMS m/z 296.0927 [M + H]+ (calcd for 
C17H14NO4, 296.0923). 
Dasymaschalolactone (17): colorless viscous oil; UV (MeOH) λmax (log ε) 295 (3.17), 
237 (3.64), 208 (4.35) nm; IR (neat) νmax 2950, 2901, 1750, 1604, 1180 cm
-1; 1H NMR (600 
MHz, acetone-d6) δH 7.72 (1H, dd, J = 8.2, 7.5 Hz, H-5), 7.16 (1H, dd, J = 7.5, 0.8 Hz, H-4), 
7.11 (1H, d, J = 8.2, H-6), 5.28 (1H, s, H-3), 3.96 (3H, s, OMe-7); 13C NMR (150 MHz, acetone-
d6) δC 169.5 (C-1), 158.6 (C-7), 150.1 (C-3a), 135.6 (C-5), 113.5, (C-4), 112.9 (C-7a), 110.2 (C-
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6), 67.8 (C-3), 59.2 (OMe-7); HRESITOFMS m/z 165.0553 [M + H]+ (calcd for C9H9O3, 
165.0552). 
α-Glucosidase inhibitory Assay. A colorimetric α-glucosidase (Sigma, St. Louis, MO, 
USA, cat. No. G5003) assay was performed using the previously reported method.40 Acarbose 
was used as a positive control with an IC50 value of 73.7 µM. 
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Chart 1. Compounds isolated from the twig extracts of D. dasymaschalum.  
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Figure 1. Key HMBC correlations for compounds 1-5 and 17 
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Table 1. 1H NMR (600 MHz) Spectroscopic Data of Compounds 1-5 in Acetone-d6 (δ in ppm, J 
in Hz) 
position 1 2 3 4 5 
2     7.71, s 
5 8.86, d (8.5)    9.24, d (9.0) 
6 7.51, t (8.5) 7.16, dd (7.7, 1.1) 7.06, dd (7.7, 1.4) 7.13, dd (7.6, 1.1) 7.19, dd (9.0, 2.8) 
7 7.17, d (8.5) 7.52, t (7.7) 7.49, t (7.7) 7.52, t (7.6)  
8  7.49, dd (7.7, 1.1) 7.45, dd (7.7, 1.4) 7.49, dd (7.6, 1.1) 7.44, d (2.8) 
8a      
9 7.73, s 7.19, s 7.29, s 7.20, s 7.14, s 
OMe-2 4.51, s 4.44, s 4.14, s 3.90, s  
OMe-3 4.19, s 3.95, s 4.47, s 3.98, s 4.13, s 
OMe-4 4.00, s 3.93, s 4.08, s   
OH-5   10.88, s   
OMe-5  4.09, s  4.08, s  
OMe-7     3.96, s 
OMe-8 4.07, s     
NH 9.86, br s 9.78, s 9.96, s 9.62, s 9.60, s 
 
 
Table 2. 13C NMR (150 MHz) Spectroscopic Data Compounds 1-5 in Acetone-d6 (δ in ppm) 
position 1 2 3 4 5 
1 108.9 111.4 111.6 104.5 106.5 
2 153.6 153.1 151.5 156.5 106.1 
3 156.4 156.7 152.7 143.4 147.8 
4 146.0 146.5 146.4 149.6 147.6 
4a 115.5 114.0 115.1 112.8 120.3 
4b 126.7 115.6 113.6 116.1 114.5 
5 118.4 157.2 154.7 156.9 128.8 
6 124.9 106.6 113.8 106.6 113.4 
7 105.9 126.8 127.9 120.6 157.9 
8 155.1 120.3 120.2 126.2 109.9 
8a 123.8 135.4 135.9 135.3 136.9 
9 98.2 104.5 106.3 104.9 103.6 
9a 133.5 133.0 133.7 125.9 116.4 
10 125.1 126.8 125.5 128.3 123.8 
C=O 165.7   166.9 168.2 
OMe-2 61.7 61.6 63.3 59.7  
OMe-3 59.8 59.9 61.9 60.1 56.3 
OMe-4 60.5 60.3 60.9   
OMe-5  54.8  54.8  
OMe-6     54.3 
OMe-7 54.8     
 
 
 
 
 
 
 
 
 
18 
 
Table of Content 
 
